Form D · Other Technology
Laguna Biotherapeutics Inc.
Berkeley, CA · CIK 0001952403
Offering snapshot reported Oct 28, 2022 · SEC filing
- Reported sold
- $1.53M Offering amount: $1.53M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 13, 2022 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 28, 2022 | Initial | $1,525,000 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-463089
Source: Form D, filed Oct 28, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Russell Carrington | Director, Executive |
| Jonathan Kotula | Director, Executive |
| Daniel Portnoy | Director |
Issuer details
Industry: Other Technology (See others in industry)
Address:
2315 6 Th Street
Berkeley, CA, 94710
Berkeley, CA, 94710